Hydroxyacyl-CoA Dehydrogenase (HADH) Peptide
Quick Overview for Hydroxyacyl-CoA Dehydrogenase (HADH) Peptide (ABIN936175)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- YPMGPFELLD YVGLDTTKFI VDGWHEMDAE NPLHQPSPSL NKLVAENKFG
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HADH antibody,
Alternative Names: HADH control peptide, HADH antibody Blocking Peptide, Anti-HADH Blocking Peptide, Hydroxyacyl-Coenzyme A Dehydrogenase Blocking Peptide, HAD Blocking Peptide, HADH1 Blocking Peptide, HADHSC Blocking Peptide, HHF4 Blocking Peptide, M/SCHAD Blocking Peptide, MGC8392 Blocking Peptide, SCHAD Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- HADH (Hydroxyacyl-CoA Dehydrogenase (HADH))
-
Background
- HADH functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. This gene is a member of the 3-hydroxyacyl-CoA dehydrogenase gene family. The encoded protein functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene.
-
Molecular Weight
- 33 kDa
Target
-